333 related articles for article (PubMed ID: 19753129)
1. Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy.
Tsochatzis EA; Papatheodoridis GV; Archimandritis AJ
Mediators Inflamm; 2009; 2009():831670. PubMed ID: 19753129
[TBL] [Abstract][Full Text] [Related]
2. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.
Stojsavljević S; Gomerčić Palčić M; Virović Jukić L; Smirčić Duvnjak L; Duvnjak M
World J Gastroenterol; 2014 Dec; 20(48):18070-91. PubMed ID: 25561778
[TBL] [Abstract][Full Text] [Related]
3. Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese.
Wong VW; Wong GL; Yu J; Choi PC; Chan AW; Chan HY; Chu ES; Cheng AS; Chim AM; Chan FK; Sung JJ; Chan HL
Am J Gastroenterol; 2010 Jan; 105(1):132-8. PubMed ID: 19809411
[TBL] [Abstract][Full Text] [Related]
4. Adipokines in liver diseases.
Marra F; Bertolani C
Hepatology; 2009 Sep; 50(3):957-69. PubMed ID: 19585655
[TBL] [Abstract][Full Text] [Related]
5. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
Krawczyk K; Szczesniak P; Kumor A; Jasinska A; Omulecka A; Pietruczuk M; Orszulak-Michalak D; Sporny S; Malecka-Panas E
J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485
[TBL] [Abstract][Full Text] [Related]
6. Adipokines and cytokines in non-alcoholic fatty liver disease.
Jarrar MH; Baranova A; Collantes R; Ranard B; Stepanova M; Bennett C; Fang Y; Elariny H; Goodman Z; Chandhoke V; Younossi ZM
Aliment Pharmacol Ther; 2008 Mar; 27(5):412-21. PubMed ID: 18081738
[TBL] [Abstract][Full Text] [Related]
7. Role of adipokines and cytokines in non-alcoholic fatty liver disease.
Abenavoli L; Peta V
Rev Recent Clin Trials; 2014; 9(3):134-40. PubMed ID: 25514909
[TBL] [Abstract][Full Text] [Related]
8. [Adipocitokines and nonalcoholic steatohepatitis].
Lăcătuşu C; Mihai B; Cijevschi-Prelipcean C; Mihai C; Graur M
Rev Med Chir Soc Med Nat Iasi; 2008; 112(4):882-9. PubMed ID: 20209757
[TBL] [Abstract][Full Text] [Related]
9. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease.
Musso G; Gambino R; Durazzo M; Biroli G; Carello M; Fagà E; Pacini G; De Michieli F; Rabbione L; Premoli A; Cassader M; Pagano G
Hepatology; 2005 Nov; 42(5):1175-83. PubMed ID: 16231364
[TBL] [Abstract][Full Text] [Related]
10. Adipokines: the missing link between insulin resistance and obesity.
Antuna-Puente B; Feve B; Fellahi S; Bastard JP
Diabetes Metab; 2008 Feb; 34(1):2-11. PubMed ID: 18093861
[TBL] [Abstract][Full Text] [Related]
11. [Adipokine interrelationship with the liver].
Takei Y; Sato N
Nihon Rinsho; 2006 Jun; 64(6):1083-7. PubMed ID: 16768113
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines.
Jamali R; Arj A; Razavizade M; Aarabi MH
Medicine (Baltimore); 2016 Feb; 95(5):e2630. PubMed ID: 26844476
[TBL] [Abstract][Full Text] [Related]
13. Adipokines in nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Mantzoros CS
Metabolism; 2016 Aug; 65(8):1062-79. PubMed ID: 26725002
[TBL] [Abstract][Full Text] [Related]
14. [The role of adipokines and insulin resistance in the pathogenesis of nonalcoholic fatty liver disease].
Orlik B; Handzlik G; Olszanecka-Glinianowicz M
Postepy Hig Med Dosw (Online); 2010 May; 64():212-9. PubMed ID: 20498498
[TBL] [Abstract][Full Text] [Related]
15. Leptin: the prototypic adipocytokine and its role in NAFLD.
Procaccini C; Galgani M; De Rosa V; Carbone F; La Rocca C; Ranucci G; Iorio R; Matarese G
Curr Pharm Des; 2010 Jun; 16(17):1902-12. PubMed ID: 20370676
[TBL] [Abstract][Full Text] [Related]
16. [Candidate drugs for non-alcoholic steatohepatitis (NASH)].
Terai S; Matsumoto T; Sakaida I
Nihon Yakurigaku Zasshi; 2007 Apr; 129(4):271-5. PubMed ID: 17435339
[No Abstract] [Full Text] [Related]
17. Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosis.
Tilg H
Curr Pharm Des; 2010 Jun; 16(17):1893-5. PubMed ID: 20370678
[TBL] [Abstract][Full Text] [Related]
18. Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH.
Musso G; Gambino R; Pacini G; Pagano G; Durazzo M; Cassader M
Hepatology; 2009 Feb; 49(2):426-35. PubMed ID: 19105201
[TBL] [Abstract][Full Text] [Related]
19. The new adipose tissue and adipocytokines.
Bulcão C; Ferreira SR; Giuffrida FM; Ribeiro-Filho FF
Curr Diabetes Rev; 2006 Feb; 2(1):19-28. PubMed ID: 18220614
[TBL] [Abstract][Full Text] [Related]
20. Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery.
Argentou M; Tiniakos DG; Karanikolas M; Melachrinou M; Makri MG; Kittas C; Kalfarentzos F
Obes Surg; 2009 Sep; 19(9):1313-23. PubMed ID: 19693638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
